Fraser syndrome 1 is a rare genetic condition that affects how parts of the body form before birth. Features often include fused or webbed fingers or toes, closed or small eyelids, and differences in the genitals or kidneys. Many living with Fraser syndrome 1 are identified in pregnancy or at birth, and features are lifelong but vary in severity. Serious kidney or airway problems can be life-threatening in infancy, but many people do well with timely care. Treatment focuses on supportive care and surgeries to improve breathing, vision, hand and foot function, and kidney health.
Overview
Fraser syndrome 1Symptoms
Fraser syndrome 1 shows at-birth features like fused or missing eyelids or eyes, webbed or fused fingers or toes, and facial differences. Some babies have kidney, genital, or airway anomalies that affect breathing or feeding. Many signs appear on prenatal ultrasound.
Outlook and prognosis
Most babies with Fraser syndrome 1 need care from multiple specialists early on, especially for breathing, feeding, eye, and genital differences. With timely surgeries and ongoing support, many grow, learn, and take part in everyday life. Outlook varies by which organs are affected and how early treatment begins.
Causes and risk factors
Genetic causes of Fraser syndrome 1 usually involve changes in the FRAS1 gene, inherited autosomal recessively. Risk is higher when both parents are carriers or closely related; new mutations are rare. No proven environmental causes; modifiers may influence severity.
Genetic influences
Genetics is central in Fraser syndrome 1. It’s caused by inherited changes in genes like FRAS1, FREM2, or GRIP1, usually in an autosomal recessive pattern. Family history, consanguinity, and carrier status strongly shape risk and recurrence.
Diagnosis
Doctors usually recognize Fraser syndrome 1 from characteristic features seen at birth or on prenatal ultrasound. The diagnosis is confirmed with genetic tests and, when needed, imaging or eye examinations. Ask about genetic diagnosis of Fraser syndrome 1.
Treatment and drugs
Treatment for Fraser syndrome 1 is individualized, often coordinated by a craniofacial and pediatric team. Care may include surgeries to open fused eyelids or digits, airway support, kidney monitoring, and therapies for feeding, speech, and development. Genetic counseling helps families plan care.
Symptoms
Fraser syndrome 1 affects multiple parts of the body from birth, most often the eyes, fingers and toes, and the urinary and genital systems. Many of the early features of Fraser syndrome 1 are noticeable at birth or on a prenatal scan. Features vary from person to person and can change over time. Care often involves several specialists focused on breathing, feeding, vision, hearing, and kidney health.
Eyelids may be missing or fused, and the eyes can be partially or fully covered by skin. Clinicians call this cryptophthalmos, which means the eyelids didn’t form and the eye surface may be hidden. Vision is often reduced and may be absent in the affected eye or eyes.
Fingers or toes may be webbed or joined, which can affect grip, writing, or shoe fit. This feature, common in Fraser syndrome 1, is called syndactyly. Hand or foot surgery and therapy can improve function.
One or both kidneys may be missing, small, or shaped differently, and the tubes that drain urine can be narrow or blocked. This can lead to urinary infections or high blood pressure and needs regular monitoring. Some children with Fraser syndrome 1 need procedures to protect kidney function.
The opening of the urethra may be in a different place, testes may not descend, or genitals may look different than expected. These differences can affect urination or future fertility. Urology and surgical teams help plan care.
How people usually first notice Fraser syndrome 1?
Many families first notice signs of Fraser syndrome 1 during pregnancy, when an ultrasound shows features like fused eyelids (ablepharon/cryptophthalmos), missing or blocked kidneys, reduced amniotic fluid, or differences in fingers and toes. At birth, doctors often recognize the first signs of Fraser syndrome 1 by the partially or completely fused eyelids, webbed or fused digits, ear or airway differences, and, in some babies, genital or kidney abnormalities that need urgent evaluation. Sometimes the condition is first noticed because of breathing difficulties right after delivery or because routine newborn exams reveal these structural differences.
Types of Fraser syndrome 1
Fraser syndrome 1 is a genetic condition with a few recognized clinical variants tied to different genes in the same biological pathway. These variants can look very similar, but certain features and severity can differ from family to family. Symptoms don’t always look the same for everyone. When people search for types of Fraser syndrome, they’re usually asking about these gene-based variants and how they relate to features like eye development, fused fingers or toes, kidney formation, and breathing passages.
FRAS1-related
Caused by changes in the FRAS1 gene. Often linked with more classic features such as fused fingers or toes, eye anomalies, and urinary or kidney differences. Severity can range from mild limb findings to life‑limiting organ issues.
FREM2-related
Due to variants in the FREM2 gene, which partners with FRAS1 in tissue development. Features overlap substantially with FRAS1-related cases, including skin adhesions and airway or kidney involvement. Some families report a similar pattern but with variable severity between relatives.
FREM1-related
Involves the FREM1 gene, part of the same extracellular matrix complex. May present with overlapping features but, in some reports, can skew toward craniofacial or nasal passage differences. Limb and eye findings can still occur but are sometimes less prominent.
GRIP1-related
Caused by changes in the GRIP1 gene that helps position the FRAS/FREM proteins. Features generally mirror other Fraser syndrome variants, including eye and limb differences. Some cases suggest a broad severity range, from compatible-with-life presentations to severe, early complications.
What genetics can tell you about symptoms
Some people with Fraser syndrome 1 develop fused eyelids, webbed fingers or toes, and kidney or airway differences because variants in FRAS1-related genes disrupt proteins that guide early tissue separation. When these “cell‑to‑cell glue” signals falter, tissues stick together or form abnormally.
Causes and risk factors
Fraser syndrome 1 is caused by harmful changes in the FRAS1 gene. It is inherited in an autosomal recessive way, so a child is affected only when both parents are carriers. When two carriers have a child, the chance of Fraser syndrome 1 is 25% in each pregnancy. Doctors distinguish between risk factors you can change and those you can’t. Being related by blood raises the chance that both parents carry the same gene change, and everyday exposures or lifestyle do not cause Fraser syndrome 1.
Environmental and biological risk factors
It’s natural to wonder what in the body or environment might raise the chance of Fraser syndrome 1. Doctors often group risks into internal (biological) and external (environmental). At this time, well-established environmental risk factors for Fraser syndrome 1 have not been identified, and the biological factors listed below have not shown consistent links in studies. The points below summarize what research suggests—and just as important, what it has not found.
Current research has not found a consistent link between common environmental exposures and Fraser syndrome 1. High-dose radiation, heavy metals, or hormone-disrupting chemicals have not been shown to cause this condition.
Infections during pregnancy can raise the risk of some birth defects, but they have not been shown to increase the chance of Fraser syndrome 1. Standard prenatal infection screening remains important for overall pregnancy health.
Older maternal age is a risk factor for certain conditions present at birth, but it is not known to affect the likelihood of Fraser syndrome 1. No clear age-related pattern has been observed in parents.
Older paternal age is linked to some conditions, yet no association has been demonstrated with Fraser syndrome 1. Available reports do not show a consistent pattern by paternal age.
Genetic risk factors
Fraser syndrome 1 is caused by inherited changes in a gene called FRAS1. The genetic causes of Fraser syndrome 1 follow an autosomal recessive pattern, where a child is affected only when they receive a nonworking copy from each parent. For families with two carriers, each pregnancy has a 25% (1 in 4) chance of an affected child. People with the same risk factor can have very different experiences.
FRAS1 gene variants: Changes in the FRAS1 gene disrupt early tissue development, which leads to the features seen in Fraser syndrome 1. Most affected children have harmful changes in both copies of FRAS1.
Autosomal recessive pattern: Fraser syndrome 1 occurs when two nonworking copies of FRAS1 are inherited—one from each parent. Each pregnancy for two carriers has a 25% (1 in 4) chance to be affected.
Carrier status: Parents are typically healthy carriers with one nonworking and one working copy of FRAS1. Carriers do not have Fraser syndrome 1 but can pass the nonworking copy to their children.
Parental relatedness: When parents are related by blood, they are more likely to carry the same FRAS1 change. This raises the chance their child will have Fraser syndrome 1.
Loss-of-function changes: Many FRAS1 changes stop the gene early or block the protein from forming correctly. This loss of function interrupts how skin and organs anchor during fetal growth.
Family history: Having a sibling or relative with a known FRAS1 change signals a higher chance of being a carrier. Knowing the exact family variant helps clarify personal risk for Fraser syndrome 1.
Other Fraser genes: Some families with Fraser syndrome have changes in FREM2 or GRIP1, which are classified as different subtypes. If FRAS1 testing is negative but clinical features fit, doctors may look at these related genes.
Variable severity: Even with the same FRAS1 changes, features can range from mild to severe in Fraser syndrome 1. This variability means prognosis can differ between siblings.
Lifestyle risk factors
Fraser syndrome 1 is present from birth; lifestyle habits do not cause it, but they can shape daily function, recovery, and complications. Understanding how lifestyle affects Fraser syndrome 1 helps families prioritize routines that support breathing, kidney health, mobility, and development. The elements below focus on choices that influence symptom management and surgical outcomes over time.
Adequate protein and calories support growth and healing after the reconstructive surgeries common in Fraser syndrome 1. Excess weight can complicate airway management and stress joints and surgical sites.
Consistent fluid intake supports kidney health when renal anomalies are present in Fraser syndrome 1. Dehydration increases urinary tract infection risk and may worsen renal function.
Regular, supervised exercises maintain range of motion and function with syndactyly or limb differences. Overexertion or high-impact activity can damage reconstructions or increase fall risk.
Adhering to post-surgical care, splinting, and scar management reduces infection and contractures. Poor hygiene or missed care can lead to wound breakdown and additional surgeries.
Risk prevention
Fraser syndrome 1 is a genetic condition, so you can’t fully prevent it from occurring, but you can lower risks around complications and plan ahead. For families with a history, recognizing early symptoms of Fraser syndrome 1 in a previous child can shape planning for future pregnancies. Knowing your risks can guide which preventive steps matter most. Care often focuses on prenatal planning, safe delivery, and lifelong monitoring to protect breathing, kidneys, vision, and overall development.
A genetics specialist can explain inheritance patterns and your chance of having a child with Fraser syndrome 1. They can also discuss testing options and support informed family planning.
Blood or saliva tests can check if you and your partner carry the genetic change. Results help estimate risks and guide choices before pregnancy.
With IVF, embryos can be tested before transfer to reduce the chance of Fraser syndrome 1 in a pregnancy. This option isn’t right for everyone, but it can be considered if both partners are carriers.
High‑resolution ultrasound (and sometimes fetal MRI) can look for features linked to Fraser syndrome 1. Early findings allow time to plan care and delivery at a well-equipped center.
Transmission
Fraser syndrome 1 is not contagious; it doesn’t spread between people. It is inherited in an autosomal recessive pattern: usually both parents are healthy carriers of one non-working copy of the gene, and with each pregnancy there’s a 1 in 4 (25%) chance the child will have Fraser syndrome 1, a 1 in 2 (50%) chance the child will be a carrier, and a 1 in 4 (25%) chance the child will inherit two working copies. This is how Fraser syndrome 1 is inherited—the genetic transmission of Fraser syndrome 1. Rarely, a child can be affected because of a new gene change alongside a carrier parent, and the chance can be higher when parents are closely related.
When to test your genes
Consider genetic testing if Fraser syndrome 1 runs in your family, a relative has features of the condition, or you’re planning a pregnancy and want carrier screening. Testing helps confirm a diagnosis, guide care, and inform reproductive options, including prenatal or preimplantation testing. Ask a genetics professional to choose the right test and timing.
Diagnosis
Fraser syndrome 1 is usually recognized by a pattern of features seen before birth or soon after delivery, then confirmed with specific tests. Doctors look for combinations such as fused fingers or toes, eye covering (cryptophthalmos), and kidney or airway differences. Genetic testing may be offered to clarify risk or guide treatment. When possible, a genetic diagnosis of Fraser syndrome 1 helps with care planning for the baby and future pregnancies.
Providers look for hallmarks like webbed or fused digits, eye covering, and differences in the genitals or ears. The overall pattern helps distinguish Fraser syndrome 1 from other conditions with overlapping features.
During pregnancy, ultrasound may show findings such as very low amniotic fluid, kidney differences, limb webbing, or facial changes. These clues can raise concern for Fraser syndrome 1 before birth.
A blood or saliva sample can be tested for changes in the FRAS1 gene, which confirms Fraser syndrome 1. Some labs use a broader gene panel to check related genes when the result is unclear.
A detailed family and health history can help identify inherited patterns and guide which tests to run. If a hereditary factor is suspected, your doctor may suggest a referral to a genetics specialist.
Stages of Fraser syndrome 1
Fraser syndrome 1 does not have defined progression stages. It’s a congenital condition, meaning its main features are present from birth and vary in severity from person to person rather than appearing in stepwise phases. Different tests may be suggested to help confirm the diagnosis and map out care. Doctors look at early symptoms of Fraser syndrome 1—such as eye or finger differences noted soon after birth or on prenatal ultrasound—and may offer genetic testing to confirm and to guide family planning.
Outlook and prognosis
Looking at the long-term picture can be helpful. Fraser syndrome 1 affects multiple body systems from birth, so the outlook depends on which organs are involved and how severe those changes are. Many babies need surgery early on—for example, to open blocked airways, repair kidney or urinary tract differences, or address eye and eyelid fusion—followed by ongoing specialty care. Early care can make a real difference, especially when breathing and kidney function are protected in the first weeks of life.
Survival to adulthood is possible, but the risk of infant mortality is higher than average, mainly when airway blockage, severe kidney problems, or major structural differences are present. When these life‑threatening issues are managed, many children with Fraser syndrome 1 grow and learn, though they may face vision differences, speech delays, or hearing loss that benefit from therapy and assistive devices. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including access to coordinated surgical and developmental care.
Over time, most people who have milder organ involvement can attend school, communicate, and participate in daily activities with supports tailored to their needs. Kidney health remains a key predictor: ongoing monitoring helps catch changes early, and some may eventually need dialysis or a transplant. Knowing what to expect can ease some of the worry, and talking through early symptoms of Fraser syndrome 1 that warrant urgent care—like breathing trouble, poor feeding, or swelling—can help families act quickly. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Fraser syndrome 1 is a lifelong genetic condition, and the outlook depends on how severe the eye, airway, kidney, and limb differences are. Many families first notice early symptoms of Fraser syndrome 1 in the newborn period, but the long-term picture depends on which organs are affected. Long-term effects vary widely, with some people facing serious kidney or breathing complications and others living into adulthood with stable health and sensory differences. Vision, kidney function, and airway structure usually shape day-to-day life the most.
Outcomes depend on which organs were involved at birth. Severe kidney or airway malformations can lead to critical illness early in life. Those without life-threatening organ issues may reach adulthood.
Eye fusion and other eye differences often cause severe visual impairment or blindness. Some retain partial light perception or vision in one eye. Daily routines may adjust around vision needs.
Laryngeal or tracheal differences can cause noisy breathing and a higher risk of airway narrowing. Respiratory stability in later childhood often reflects how severe the early airway differences were. Voice quality may remain hoarse or weak.
Missing or underdeveloped kidneys can lead to chronic kidney disease over time. High blood pressure and urinary infections may occur as secondary effects. Lifespan may be influenced by kidney function.
How is it to live with Fraser syndrome 1?
Living with Fraser syndrome 1 often means coordinating multiple specialists and procedures over time, especially in childhood, to address features like eye differences, breathing or airway concerns, urinary or genital differences, and webbing of fingers or toes. Daily life can involve extra planning for medical visits, therapies, and school supports, but many families build steady routines that make care feel more manageable. People with Fraser syndrome 1—and those who love them—may navigate communication challenges, accessibility needs, and social questions, yet strong care teams, early interventions, and community connections can ease the load and help children participate fully at home, in school, and in play. Family members and caregivers often become skilled advocates, balancing vigilance with celebrating progress and everyday milestones.
Treatment and drugs
Fraser syndrome 1 is treated by a coordinated care team, with plans tailored to the features each person has at birth and as they grow. Early on, surgeons often address urgent structural issues such as blocked airways, fused eyelids, or urinary tract problems to help with breathing, vision, and kidney function. Ongoing care can include eye protection and later eyelid separation, hearing support, speech and physical therapy, and monitoring of kidneys with prompt treatment of infections or high blood pressure. Treatment plans often combine several approaches, and regular check-ins help adjust care as needs change over time. Supportive care can make a real difference in how you feel day to day.
Non-drug treatment
Living with Fraser syndrome 1 often means planning care early to support breathing, feeding, vision, movement, and development. Non-drug treatments often lay the foundation for daily function, with surgery and therapies timed to your child’s needs. Care usually involves a team approach so families aren’t navigating this alone. Plans can change over time as growth brings new challenges and opportunities.
Early evaluation ensures the nose, throat, and windpipe are open and safe. Some babies with Fraser syndrome 1 need positioning, specialized breathing support, or a tracheostomy to keep airflow steady.
Feeding therapy can improve latch, coordination, and swallowing safety. If oral feeds are not sufficient, temporary tube feeding or a gastrostomy can help with nutrition and growth.
Lubricating drops, moisture chambers, or protective shields help protect the eye surface. Staged surgery may be planned to open fused eyelids and improve comfort or vision.
Orientation and mobility training, contrast tools, and lighting adjustments support safe movement and learning. School accommodations and assistive technology help children with Fraser syndrome 1 access reading and play.
Your genes may have an impact on how drugs work for you
Medicines used in Fraser syndrome 1 can work differently based on small DNA differences that affect how the body absorbs, breaks down, and clears drugs. Genetic testing can sometimes guide dosing or drug choice, helping avoid side effects and improve benefit.
Pharmacological treatments
There’s no medicine that fixes the underlying gene change in Fraser syndrome 1; care focuses on surgeries and supportive drugs that make daily life safer and more comfortable. Drugs that target symptoms directly are called symptomatic treatments. Medicines are chosen to protect the kidneys, prevent infections, ease pain, and support eye and wound healing in Fraser syndrome. In practice, medications for Fraser syndrome 1 are mainly supportive and individualized over time.
Trimethoprim–sulfamethoxazole or nitrofurantoin may be used to prevent repeat urinary infections when kidney or urinary tract differences are present. This can lower the risk of scarring in children living with Fraser syndrome.
Amoxicillin–clavulanate or cephalexin are commonly prescribed to treat urinary infections, adjusted to culture results. Severe infections may need a hospital antibiotic such as ceftriaxone.
Enalapril or lisinopril (ACE inhibitors) can reduce protein in the urine and help control blood pressure to protect the kidneys. Losartan (an ARB) is an alternative if ACE inhibitors aren’t tolerated.
Acetaminophen or ibuprofen can relieve post‑procedure pain and fever. Avoid or limit ibuprofen if there are kidney problems or your surgeon advises against it.
Genetic influences
Fraser syndrome 1 most often arises when the FRAS1 gene, which helps tissues form and adhere properly early in development, isn’t working as it should. A change in a gene (mutation or variant) can sometimes affect health. The condition follows an autosomal recessive pattern: usually each parent carries one silent change, and with each pregnancy there is a 25% (1 in 4) chance the child will have Fraser syndrome 1, a 50% chance to be a carrier, and a 25% chance to inherit neither change. Because of this pattern, relatives may be healthy carriers, and even in the same family the features and severity can differ. Genetic testing for Fraser syndrome 1 looks for changes in FRAS1 (sometimes along with related genes) to confirm the diagnosis, clarify recurrence risk, and guide family planning. If you’re wondering “is Fraser syndrome 1 inherited,” a visit with a genetic counselor can help explain results in plain language and discuss options such as testing partners or prenatal testing in a future pregnancy.
Is Fraser syndrome 1 genetic?
Genetics is central in Fraser syndrome 1. It’s caused by inherited changes in genes like FRAS1, FREM2, or GRIP1, usually in an autosomal recessive pattern. Family history, consanguinity, and carrier status strongly shape risk and recurrence.
Pharmacogenetics—how genetics influence drug effects
Because Fraser syndrome 1 affects how certain tissues form before birth, care usually relies on surgeries and supportive medicines rather than a gene‑targeted drug. Changes in the FRAS1 gene do not, by themselves, point to a specific medication that works better or a standard dose adjustment for people with Fraser syndrome 1. Instead, treatment plans often reflect features linked to the condition—such as kidney differences or airway narrowing—which can influence how safe a drug is and how the body clears it, so doses of antibiotics, pain relievers, and anesthesia medicines may be tailored and monitored. Genetic testing can sometimes identify how your body processes certain pain or nausea medicines, which may help fine‑tune choices during recovery from eye, hand, or airway procedures. This type of pharmacogenetic testing in Fraser syndrome 1 is aimed at the supportive drugs you may need, not at changing the underlying FRAS1 pathway. Genes are just part of the picture; age, kidney function, and other medicines you take also guide decisions about what’s safest and most effective.
Interactions with other conditions
For many families, other health issues can shape day-to-day life with Fraser syndrome 1. Kidney and urinary tract differences that occur in Fraser syndrome 1 can lead to urinary infections or high blood pressure, and when kidney function is reduced, medicines for other conditions may need careful choice and dosing. Breathing and voice-box differences can interact with colds, asthma, or sleep apnea, sometimes making symptoms worse and increasing anesthesia risks during surgeries. Doctors call it a “comorbidity” when two conditions occur together. Vision loss and possible hearing differences can overlap with developmental or learning challenges, so coordinated support from eye, ear, and therapy teams is often helpful. Early symptoms of Fraser syndrome 1 can also be harder to sort out if prematurity or frequent infections are present, so having specialists share information and plan together can make care safer and smoother.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies born with a combination of features affecting the eyelids, kidneys, and genitals, though early accounts did not connect them as one condition. Families and midwives noticed patterns across relatives, and some communities quietly remembered cousins who shared similar differences at birth. Not every early description was complete, yet together they built the foundation of today’s knowledge.
First described in the medical literature as a recognizable pattern in the 1960s, Fraser syndrome 1 was initially pieced together from case reports of newborns with fused eyelids, webbed fingers or toes, and kidney problems. Doctors at the time relied on careful bedside observation and family histories to link these features. Over time, descriptions became more consistent, and the condition’s profile grew clearer as clinicians compared notes across hospitals and countries.
As medical science evolved, imaging and pathology studies helped explain why some babies had severe breathing difficulties, while others lived into childhood with milder findings. The wide range of outcomes led researchers to suspect more than one underlying cause or pathway. Advances in genetics then confirmed that variants in certain genes involved in early tissue separation and organ development play a central role, and that Fraser syndrome 1 sits within a small group of related conditions that can look similar in newborns.
From early theories to modern research, the story of Fraser syndrome 1 reflects a steady shift from “what we see” to “why it happens.” Genetic testing made it possible to diagnose the condition even when some classic signs are missing, and to distinguish Fraser syndrome 1 from overlapping syndromes. It also clarified inheritance, showing that two carrier parents have a one-in-four chance with each pregnancy of having a child with the condition.
In recent decades, knowledge has built on a long tradition of observation. Registries and collaborative studies brought together families and clinicians, refining diagnostic criteria and highlighting the importance of monitoring kidneys, airway, and vision from the start. This history has shaped current care: earlier recognition, coordinated specialty support, and family counseling now begin soon after birth or even during pregnancy when ultrasound raises concern. Looking back helps explain why early symptoms of Fraser syndrome 1 were once missed—and why today, a careful, team-based approach offers clearer answers and more tailored support for those living with it.